Archives for: "November 2010, 18"

The Death Panel loses round one, but should they?

Drug company Dendreon makes Provenge, the only drug on the market which shows some success in extending the life of prostate cancer victims.  However, the treatment costs $93,000 in order to get an average of an extra four months of life.  (To be clear… more »